Showing results (51-60 of 315) with videos related to
Sort By:
Pageof 32
Reviews in Urology|September 21, 2006
Adverse events associated with hormonal therapy for prostate cancerRavi J Kumar, Al Barqawi, E David CrawfordCurrent Urology Reports|October 25, 2008
Testosterone and the prostate: implications for the treatment of hypogonadal menJoshua D Holyoak, E David Crawford, Randall B MeachamThe Urologic Clinics of North America|February 16, 2010
High-intensity focused ultrasound: ready for primetimeKyle O Rove, Kathryn F Sullivan, E David CrawfordUrology|February 20, 2004
Herbal and vitamin supplement use in a prostate cancer screening populationAlbaha Barqawi, Eduard Gamito, Colin O'Donnell, et al.The Journal of Urology|September 6, 2006
Metastatic prostate cancer-does treatment of the primary tumor matter?Gregory Swanson, Ian Thompson, Joseph Basler, et al.Current Opinion in Urology|April 10, 2009
Targeted focal therapy for prostate cancer: a reviewAmy H Hou, Kathryn F Sullivan, E David CrawfordOncology (Williston Park, N.Y.)|July 2, 2011
Screening for prostate cancer with PSA testing: current status and future directionsJennifer M Croswell, Barnett S Kramer, E David CrawfordThe Journal of Urology|August 21, 2002
Impact of previous local treatment for prostate cancer on subsequent metastatic diseaseIan M Thompson, Catherine Tangen, Joseph Basler, et al.Clinical Prostate Cancer|April 10, 2004
Biochemical recurrence and survival prediction models for the management of clinically localized prostate cancerAshuthosh Tewari, Eduard J Gamito, E David Crawford, et al.BJU International|June 9, 2007
The association of time of day and serum testosterone concentration in a large screening populationE David Crawford, Al Baha Barqawi, Colin O'Donnell, et al.Pageof 32